SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

20 Oct 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 0.36 million declined by -96.64% from Rs. 10.71 millions.The Company to register a -59.47%  fall in the net profit for the quarter ended September 2021.Operating profit for the quarter ended September 2021 decreased to 2.02 millions as compared to 4.68 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.36 10.71 -96.64 0.59 13.63 -95.67 69.91 33.96 105.86
Other Income 4.27 3.69 15.72 8.05 5.63 42.98 14.66 14.65 0.07
PBIDT 2.02 4.68 -56.84 3.03 5.07 -40.24 23.12 10.59 118.32
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.02 4.68 -56.84 3.03 5.07 -40.24 23.12 7.95 190.82
Depreciation 0.18 0.14 28.57 0.32 0.28 14.29 0.58 0.58 0.00
PBT 1.84 4.54 -59.47 2.71 4.79 -43.42 22.54 7.37 205.83
TAX 0.00 0.00 0.00 0.00 -0.06 0.00 8.05 -0.17 -4835.29
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 4.48 -0.20 -2340.00
PAT 1.84 4.54 -59.47 2.71 4.85 -44.12 14.49 7.54 92.18
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 561.11 43.70 1184.08 513.56 37.20 1280.63 33.07 31.18 6.05

Emmessar Biotech&Nut Share Price

26.29 -0.70 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×